DARPA's 2016 'PROMETHEUS' Project: Declare People Contagious Without Symptoms to Enable 'Quarantine' and Medical Interventions
What happens when computer models—not symptoms—become the basis for quarantine?
In 2016, the Defense Advanced Research Projects Agency (DARPA) launched PROMETHEUS (here), a military research program designed to determine whether a person was “likely to spread disease” without exhibiting symptoms of illness, with the stated goal of enabling quarantine and medical interventions.
The revelation follows HHS’s recent quarantine of a symptomless American against her will after testing negative for hantavirus.
PROMETHEUS represents one of the clearest examples in DARPA’s biotechnology portfolio of an effort to move purported infectious disease response away from waiting for observable illness and toward “predictive” analysis of claimed genetic changes occurring inside the human body.
It also raises broader questions about how governments may increasingly rely on computer models—rather than observable clinical evidence—to make drastic public health determinations.
It also raises obvious questions:
What happens when a computer says you’re contagious but you have no symptoms?
Could governments eventually quarantine or medically intervene based on that prediction?
And if the computer is wrong, how would you ever prove it?
Follow us on Instagram @realjonfleetwood & Twitter/X @JonMFleetwood.
If you value this reporting, consider upgrading to a paid subscription.
For advertising & sponsorship opportunities, contact us by clicking below.
Predicting Contagiousness Before Symptoms
DARPA summarized the program’s objective in unusually direct language.
According to the agency’s PROMETHEUS webpage:
“The Prometheus program aims to improve military readiness and force health through development of a prognostic that can determine if an individual is contagious before he exhibits symptoms of illness.”
The agency further explained:
“DARPA’s goal is to develop a molecular test for determining if an individual is likely to spread disease following exposure to an infectious agent and predict within 24 hours of exposure if that individual will become contagious.”
According to DARPA, the capability would allow military planners to identify potentially contagious individuals before they transmitted disease within the close quarters common in military operations.
The accompanying Broad Agency Announcement (BAA) similarly states that the program sought to:
“...develop a molecular host prognostic assay to measure infectious disease contagiousness” and identify individuals “in advance of diagnostics or symptom reporting for potential interventions.”
Rather than waiting for symptoms or conventional diagnosis, PROMETHEUS proposed using molecular biomarkers to predict contagiousness before either occurred.
Looking Inside the Human Body
To accomplish that, DARPA proposed identifying a minimal collection of biological signals capable of forecasting contagiousness shortly after exposure.
According to the agency:
“Prometheus specifically aims to discover a minimal set of biological signals in a person recently infected with disease that would indicate the potential for contagiousness...”
Those biological signals—or biomarkers—would be identified by characterizing a person’s genetic and molecular immune responses over time.
The BAA describes measuring messenger RNA, host genetic mutations, immune-response proteins, cytokines, metabolites, genomics, proteomics, metabolomics, epigenomics, and pre-existing immunity to identify early molecular signatures associated with future contagiousness.
Those data would then be integrated using advanced computational modeling.
According to the BAA:
“The DARPA Prometheus program seeks to advance our understanding... by... performing advanced, integrative analytics and predictive modeling...”
DARPA claimed to seek:
“95% accuracy with minimal set of biomarkers for predicting contagiousness within 24 hours of exposure to a pathogen.”
Predicting Who May Never Appear Sick
One of the least-discussed objectives appears in DARPA’s own program summary.
The agency stated that researchers aimed to:
“...develop advanced analytics to predict which individuals will become contagious and whether or not they will show symptoms.”
In other words, the program was not limited to forecasting contagiousness.
It also sought to predict whether a person would ever become symptomatic.
That objective reflects DARPA’s view that some individuals may spread respiratory infections before—or even without—developing observable illness.
The BAA echoes this concern, stating:
“The spread of many acute infections is caused by people who are contagious prior to developing symptoms.”
DARPA argued that waiting for clinical diagnosis or symptom reporting produced incomplete surveillance because many contagious individuals either had mild symptoms or never sought medical care.
From ‘Prediction’ to Quarantine
DARPA did not present PROMETHEUS as simply an academic research project.
The agency explicitly described how it believed the capability could be used operationally: quarantining symptomless individuals.
According to DARPA:
“A successful prognostic capability would enable early treatment of infected individuals or the initiation of other mitigating steps (e.g., quarantine) before a disease can be transmitted to others.”
DARPA further stated:
“Technologies developed in this program could enable the earliest possible clinically actionable information and extend infectious disease forecasting into a real-time, accurate support tool for military planners.”
The BAA similarly states that identifying individuals before diagnostics or symptom reporting would enable “potential interventions” and improve outbreak response.
In other words, PROMETHEUS was designed not merely to forecast disease transmission, but to produce information intended to support drastic disease-response decisions before symptoms appeared.
The Larger Questions
PROMETHEUS raises questions that extend well beyond military medicine.
If governments develop the capability to identify people as likely contagious before symptoms or conventional diagnosis, what evidentiary standard governs those determinations?
When does a computational prediction become sufficient to trigger quarantine or other public health interventions?
If someone feels healthy, exhibits no observable illness, and has not received a conventional diagnosis, what evidence could they present to challenge the prediction?
Would they have access to the underlying algorithm?
Would independent researchers be permitted to examine the model and the reference datasets on which it was trained?
What mechanisms would exist to identify false positives before interventions are imposed?
Could the prediction itself eventually become the operative evidence?
Like many military-developed technologies, PROMETHEUS also raises questions about dual use.
Could capabilities initially developed for military force health eventually migrate into broader civilian public health systems?
Could similar predictive tools eventually be adopted by employers, schools, transportation systems, insurers, or other institutions?
If so, what safeguards would prevent mission creep?
These questions do not depend on whether the technology ultimately succeeds.
They arise from the capability DARPA proposed building.
Bottom Line
PROMETHEUS represents a notable evolution in DARPA’s approach to infectious disease response.
Rather than waiting for observable illness or conventional diagnosis, the agency proposed identifying genetic signatures in a computer capable of predicting contagiousness before symptoms appeared and using those predictions to justify earlier treatment, quarantine, and operational planning.
Viewed alongside DARPA’s broader biotechnology portfolio—including PROPHECY’s effort to anticipate future viral evolution, ECHO’s effort to infer past exposures from the human epigenome, and PREPARE’s effort to transiently modulate the body’s own protective genes—PROMETHEUS reflects the agency’s broader shift toward using computational models of human biology to generate actionable determinations before they can be established through conventional clinical observation.
As governments continue developing technologies capable of making alleged biological predictions before those predictions can be independently observed or conventionally verified, one question becomes increasingly difficult to ignore:
When public health decisions begin with algorithmic predictions rather than observable evidence, what mechanisms ensure those determinations remain transparent, independently verifiable, and accountable?
Follow us on Instagram @realjonfleetwood & Twitter/X @JonMFleetwood.
If you value this reporting, consider upgrading to a paid subscription.
For advertising & sponsorship opportunities, contact us by clicking below.
Long ago when I found out that flu injections did not stop spread, I wondered how nurses and retirement home helpers who were injected might spread disease even though symptomless or sick themselves. For years now it has been shown that jabs do not stop contagion - from the NY measles outbreak a few years ago, 60+ of the 160 sick kids were 'fully vaccinated'. How do people not notice this?
Even though it is hidden, I read the comment and agree with it. Why is military involved in healthcare at all? Since they inject their soldiers and personnel with experimental stuff how can we trust them with our health?